Two Third Party GMP Audits performed in Germany by API Compliance Institute
Register now for ECA's GMP Newsletter
The API Compliance Institute recently performed Third Party GMP Audits at two API manufacturing sites in Germany. The Audits were initiated by a group of Qualified Persons and QA Managers from different pharmaceutical companies who are using the respective APIs to manufacture their medicinal products. The initiators as well as the Auditee agreed to share the audit reports with other companies.
The GMP Audits were performed by 2 certified APIC Auditors during 2 days at each manufacturing site. They were conducted according to the rules of the APIC Audit Programme. This GMP Audit Scheme is an internationally recognized auditing programme which was established 10 years ago. It is the idea of the programme to share compliance information between companies.
The following sites were audited:
Site: Excella GmbH
Nürnberger Str. 12
90537 Feucht
and
Site: Boehringer Ingelheim Pharma GmbH & Co. KG
Binger Str. 173
55216 Ingelheim
The API Compliance Institute is responsible for the controlled distribution of the audit report in which the GMP compliance situation at the two API manufacturing sites has been described in detail. More information can be obtained from the following source: Press Release API Compliance Insitute
Related GMP News
08.01.2025PIC/S publishes Guidance Documents on Remote Assessments
04.12.2024Discarded Batch Documentation again found during Inspection
30.10.2024From missing Analysis to Brand Protection Violations - FDA Warning Letter to Canadian Manufacturer
23.10.2024Root Cause Analysis: What can be found in FDA Warning Letters?
23.10.2024Do you want to host FDA Staff? FDA announces Experiential Learning Site Visit Program
09.10.2024Management circumvents Quality Department in Deviation Classification - FDA Warning Letter